Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000244130 | SCV000304692 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV002321925 | SCV002609863 | likely benign | Cardiovascular phenotype | 2021-08-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV000508926 | SCV004830391 | likely benign | Hypercholesterolemia, familial, 1 | 2023-08-28 | criteria provided, single submitter | clinical testing | |
Laboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, |
RCV000508926 | SCV000606085 | benign | Hypercholesterolemia, familial, 1 | no assertion criteria provided | research |